Free Newsletter
Hassan to testify in Celebrex suit
Schering-Plough CEO Fred Hassan has been ordered to testify via videotape in a trial over the painkiller Celebrex, which Pfizer acquired in its merger with Pharmacia--the company that was headed up by Hassan when Celebrex was launched. Though Pfizer has settled some Celebrex lawsuits, brought by plaintiffs who said the painkiller caused their heart attacks or strokes, this is the first such suit to reach trial. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: